Is the price fair?
What PIII's price assumes
P3 Health Partners Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is read against sales instead: 0.02× revenue.
0.02
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 0.21
EV / sales
Details›
- EV / EBIToperating margin −15%: the multiple describes the denominator
- not meaningful
- EV / sales2026-Q1
- 0.21
- Market capitalisation
- $2.18B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.